It inhibits the following receptor tyrosine kinases: MET (hepatocyte growth factor receptor protein) and VEGFR, RET, GAS6 receptor (AXL), KIT), and Fms-like tyrosine kinase-3 (FLT3).
Cabozantinib
Avapritinib
Encorafenib
Sorafenib
Entrectinib
Enasidenib
Dabrafenib
Abrocitinib